Sponsor:
University of Pittsburgh
Code:
NCT00177268
Conditions
Cutaneous T-cell Lymphoma
Sezary Syndrome
Mycosis Fungoides
Eczema
Atopic Dermatitis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Blood draw, skin biopsy or urine collection
Brief summary:
Conditions
Cutaneous T-cell Lymphoma
Sezary Syndrome
Mycosis Fungoides
Eczema
Atopic Dermatitis
Study ID
NCT00177268
Start date
Oct, 2004
Status verified date
Dec, 2025
Completion date
Jan, 2032
Anticipated
Primary completion date
Jan, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Arms
CTCL, atopic dermatitis, eczema
Interventions
Blood draw, skin biopsy or urine collection
Primary outcome measure
Central contacts
Locations
University of Pittsburgh Medical Center
Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contacts
Principal Investigator:
Oleg E. Akilov, MD, Ph.D
Sponsor
University of Pittsburgh
Last update posted
Dec 30, 2025
Last verified
Dec, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by University of Pittsburgh on 2025-12-30.